Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1989 | 09-1989 | 06-1989 | 03-1989 | 12-1988 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,708 | 8,781 | 9,567 | 9,542 | 10,211 |
| Receivables | 1,206 | 614 | 629 | 367 | 374 |
| Inventories | 322 | 337 | 218 | 185 | 120 |
| Other current assets | 426 | 107 | 288 | 369 | 279 |
| TOTAL | $8,663 | $9,840 | $10,702 | $10,463 | $10,984 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 451 | 453 | 455 | 457 | 458 |
| TOTAL | $451 | $453 | $455 | $457 | $458 |
| Total Assets | $11,211 | $12,384 | $13,185 | $11,857 | $12,342 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 461 | 211 | 493 | 157 | 235 |
| Accrued Expenses | 980 | 1,349 | 1,115 | 1,095 | 926 |
| Other current liabilities | 394 | 772 | 890 | 46 | 128 |
| TOTAL | $1,835 | $2,331 | $2,498 | $1,298 | $1,289 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,835 | $2,331 | $2,498 | $1,298 | $1,289 |
| Shareholders' Equity | |||||
| Common Shares | 8 | 8 | 8 | 8 | 8 |
| Retained earnings | -7,293 | -6,610 | -5,972 | -6,099 | -5,605 |
| Other shareholders' equity | 2,279 | 2,326 | 2,326 | 2,327 | 2,327 |
| TOTAL | $9,376 | $10,052 | $10,687 | $10,559 | $11,053 |
| Total Liabilities And Equity | $11,211 | $12,383 | $13,185 | $11,857 | $12,342 |